3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
9
Phase 2
9
Phase 1
6
Phase 1/2
5
Phase EARLY_PHASE1
3
Phase 3
2
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
12
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Gastrointestinal Stromal Tumors
10
Bone Neoplasms
9
Sarcoma
8
Neoplasms
3
Multiple Myeloma
3
Sarcoma, Kaposi
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Osteosarcoma
2
Neoplasm Metastasis
2
Lymphoma
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Anemia
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma, Alveolar
1
Renal Insufficiency
1
Recurrence
1
Rectal Neoplasms
1
Psoriasis
1
Prostatic Neoplasms
1
Progressive Gastrointestinal Stromal Tumor
1
Piebaldism
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Interventions
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Gastrointestinal Neoplasms
×
Sarcoma
×
Clear all
NCT00793871
2015-11-20
GIST
Pfizer
Phase 4
Completed
60 enrolled
14 charts